Fundraising Fox

Luminopia

Aspen, US · Founded 2015 · Delaware corporation · 9 known investors

Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches. Clinically tested in US trials, the therapy is prescribed by doctors and requires one hour of use per day, six days a week.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Luminopia was founded in 2015 by DEAN A. TRAVERS, SCOTT XIAO, Scott Xiao, and Dean Travers.

DA
DEAN A. TRAVERSCo-founder
SXSCOTT XIAO
SCOTT XIAOCo-founder
SXScott Xiao
Scott XiaoCo-Founder & CEO
DTDean Travers
Dean TraversCo-Founder
BRBrion Raymond
Brion RaymondCBO
DMDrew Mowery
Drew MoweryVP of Commercial Strategy
HWHank Wu
Hank WuCOO
SASunny Atwal
Sunny AtwalVP of Engineering
AW
ALEXANDER WENDLANDNamed on SEC filing

Investors · 9

ShangBay Capital LLC✓ verifiedPalo Alto
Bantam GroupWestwood
Good FriendsSan Francisco · $250K – $1Mvia Alexandra Cowie · inferred
NXT VenturesMarblehead · $250K – $1M
Sony Ventures CorporationTokyo
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
U.S. Venture PartnersreportedMinneapolis

Also in the syndicate · 2

Broadfin AdvisorsVertical Group

Reported raises · per SEC filings

Form D private placements

$36.5M disclosed across 7 rounds · 2016–2023

▶$15.8MraisedJun 2023 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott XiaoExecutive Officer, Director
  • Casey TanseyDirector
  • Robert LangerDirector
  • Dean TraversDirector
  • William DaiDirector
  • Mark JacobsteinDirector
Offering amount
$16.8M
Amount sold
$15.8M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedOct 2022 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey DunnDirector
  • Scott XiaoExecutive Officer, Director
  • Dean TraversDirector
  • Robert LangerDirector
  • Mark JacobsteinDirector
  • Michelle LeeDirector
  • William DaiDirector
Offering amount
$5.1M
Amount sold
$4.1M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.1MraisedDec 2019 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott XiaoExecutive Officer
  • Mark JacobsteinDirector
  • Jeffrey DunnDirector
  • Dean TraversExecutive Officer, Director, Promoter
  • Joi ItoDirector
  • Robert LangerDirector
Offering amount
$13.6M
Amount sold
$11.1M
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedSep 2017 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • SCOTT XIAOExecutive Officer, Director
  • ALEXANDER WENDLANDExecutive Officer, Director
  • MARK DOCKSERExecutive Officer
  • DEAN A. TRAVERSExecutive Officer, Director, Promoter
Offering amount
$5.1M
Amount sold
$3.6M
Minimum investment
$10K
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedSep 2017 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • SCOTT XIAOExecutive Officer, Director
  • MARK DOCKSERExecutive Officer
  • DEAN A. TRAVERSExecutive Officer, Director, Promoter
  • ALEXANDER WENDLANDExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.3M
Minimum investment
$25K
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$410KraisedDec 2016 · 8 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • SCOTT XIAOExecutive Officer, Director
  • ALEXANDER WENDLANDExecutive Officer, Director
  • DEAN A. TRAVERSExecutive Officer, Director
Offering amount
$700K
Amount sold
$410K
First sale
Oct 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJul 2016 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • DEAN A. TRAVERSExecutive Officer, Director
  • SCOTT XIAOExecutive Officer, Director
  • ALEXANDER WENDLANDExecutive Officer, Director
Offering amount
$500K
Amount sold
$250K
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Luminopia went on to found or lead other companies.

Reece PachecoIndependent Consultant - PartnershipsFounded Shelby.tvRaphael RouvinovFounderFounded Swipehouse

Competitors · 3

by search overlap
Seevividly66 shared keywordsVivid Vision builds a vision care platform that uses virtual reality technology to treat conditions such as amblyopia and strabismus. The system is used by eye doctors and distributed worldwide through regional partners.
NovaSight37 shared keywordsNovaSight builds eye-tracking-based vision care products for children, including CureSight, an FDA-cleared and CE-marked at-home treatment for amblyopia (lazy eye), and TrackSight, a software solution for myopia prevention and vision health monitoring. Its technology uses optical IR sensors to track gaze and applies data analytics to support healthcare providers in pediatric vision assessment and treatment.
Warby Parker29 shared keywordsWarby Parker is a direct-to-consumer eyewear retailer offering prescription eyeglasses, sunglasses, contacts, and eye exams at affordable prices, with a home try-on service and flexible return policy.

Companies competing with Luminopia for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Luminopia ranks among best inventions of 2023glance.eyesoneyecare.com · Nov 2023VM - Luminopia, Inc. Raises Additional $16 Million in Funding Through Oversubscribed Series A Financing Roundvisionmonday.com · Jun 2023Luminopia raises $16M for digital lazy eye therapeuticmassdevice.com · Jun 2023Luminopia, Inc. Announces Closing of Oversubscribed Series A Financing Roundbusinesswire.com · Jun 2023Luminopia Raises $16M in Series A | citybizcitybiz.co · Jun 2023Luminopia Raises $5.7M in Seed Extension Financingfinsmes.com · Nov 2022

Frequently asked questions

What does Luminopia do?
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches. Clinically tested in US trials, the therapy is prescribed by doctors and requires one hour of use per day, six days a week.
Who founded Luminopia?
Luminopia was founded by DEAN A. TRAVERS, SCOTT XIAO, Scott Xiao, Dean Travers in 2015.
Who are Luminopia's investors?
Luminopia's investors include ShangBay Capital LLC, Bantam Group, Good Friends, NXT Ventures, Sony Ventures Corporation, US Venture Partners, U.S. Venture Partners.
How much funding has Luminopia raised?
Luminopia has disclosed $36.5M raised across 7 rounds.
Where is Luminopia headquartered?
Luminopia is headquartered in Aspen, US.